YSR Congress leader dies of heart attackTimes of IndiaVIJAYAWADA: Former Krishna Zilla Parishad chairman and YSRCP leader Kukkala Nageswara Rao died after he suffered a massive heart attack at his guesthouse in Machilipatnam in the early hours of Thurs…
Cadila launches lung cancer drug at Rs 40000 per course – NDTV
Cadila launches lung cancer drug at Rs 40000 per courseNDTVThe company, which spent 15 years in developing the drug for treatment of non-small-cell lung carcinoma (NSCLC), is looking to sell the drug in 50 countries in Africa and South East Asia apart …
SCT, AB Biosciences Collaborate on Antibodies Using NGS – GenomeWeb
|
SCT, AB Biosciences Collaborate on Antibodies Using NGS
GenomeWeb NEW YORK (GenomeWeb News) – Single Cell Technology and AB Biosciences today announced a collaboration aimed at identifying therapeutic antibodies. SCT will use its technology called Antibody Biologix to massively screen plasma cells and measure … Single Cell Technology and AB Biosciences Announce CollaborationHispanicBusiness.com |
Bhabha surgery department shows the way for BMC hospitals – Times of India
Bhabha surgery department shows the way for BMC hospitalsTimes of IndiaMUMBAI: To most Mumbaikars who believe complicated surgeries relating to pancreatic or liver cancer can only be performed in medical schools or five-star hospitals, it may come as a…
Breaking the Code: UCSB Researchers Link Antibodies to Certain Diseases – Noozhawk
NoozhawkBreaking the Code: UCSB Researchers Link Antibodies to Certain DiseasesNoozhawkBy cross referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Creating biochemical reagents that can accurately detect disease-associated … – Phys.Org
Creating biochemical reagents that can accurately detect disease-associated …Phys.OrgBy cross-referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Cadila to sell cheaper lung cancer drug in India by Dec – Business Standard
Business StandardCadila to sell cheaper lung cancer drug in India by DecBusiness StandardMycidac-C is for patients suffering from non-small cell lung cancer (NSCLC). Modi said the drug test showed it improved survival possibilities by 28.2 per cent and…
Old smokers who quit reap heart benefits faster – Times of India
Times of India |
Old smokers who quit reap heart benefits faster
Times of India A new study led by Indian origin researcher has suggested that cigarette smokers who are over 65 years of age may be able to lower their risk of cardiovascular disease-related deaths to the level of never-smokers when they quit faster than previously … Smokers who quit may cut heart risk faster than had been thoughtDaily News & Analysis |
Cadila Pharma launches new lung cancer drug – The Hindu
Newstrack India |
Cadila Pharma launches new lung cancer drug
The Hindu The new drug has been licensed and approved by the Drug Controller General of India (DCGI). Mycidac-C is meant for patients suffering from non-small cell lung cancer (NSCLC). “The drug is affordable, and is many times cheaper than what out competitors … Ancestor of TB germ to fight lung cancerCalcutta Telegraph Cadila Pharma launches affordable drugs for lung cancerNewstrack India Cadila launches low-cost cancer drugTimes of India Jagran Josh –India.Com Health all 22 news articles » |
Cadila Pharma to debut novel lung cancer drug Mycidac-C in India – The Pharma Letter
|
Cadila Pharma to debut novel lung cancer drug Mycidac-C in India
The Pharma Letter Cadila Pharmaceuticals, one of India’s largest privately-held pharmaceuticals company, has launched for the first time in the world, Mycidac-C, an affordable, unique and innovative drug for the treatment of lung cancer. Mycidac-C is an innovative … |